Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Ryan Mak who wrote (83265)	2/16/2000 3:45:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

Long MOGN at 30, but Closing biotech positions..leaving CEGE, ABSC, GLGC, MDYN, MEDX, GENXY for a 'basket of biotechs'.. only a few hundred of each. I think these are among the 'proven leaders' The others have given so much I can't afford to hold them and risk a reversal. I have had CNBC on Mute for most of the time. I did not even hear what they said. I just think that we might have a rest from the biotechs for a day or so. My Ben Franklin and Invesco health care mutual fund have the old faithfuls like BGEN, AMGN, MNMD, MLNM, and CHIR but I got the sightly more risky ones for my own portfolio. But I don't like the completely risky ones after they've been up 25-50%